oxazolidin-2-one has been researched along with Diarrhea in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L; Liu, Y; Sun, J; Zhang, J; Zhang, Y | 1 |
| Buitrago, M; Cornely, OA; Gerding, DN; Gheorghe Diaconescu, I; Grill, S; Kracker, H; Louie, TJ; Marrast, AC; Murta de Oliveira, C; Nord, CE; Preotescu, L; Pullman, J; Talbot, GH; Wilcox, MH | 1 |
| Baldoni, D; Dingemanse, J; Gutierrez, M; Timmer, W | 1 |
| Buitrago, M; Charef, P; Cornely, OA; Gerding, DN; Kracker, H; Louie, T; Nord, CE; Talbot, GH; Wilcox, M | 1 |
| Clozel, M; Enderlin-Paput, M; Locher, HH; Pfaff, P; Ritz, D; Seiler, P; Weiss, M | 1 |
| Alcalá, L; Bouza, E; Giannella, M; Marin, M; Muñoz, P; Pedromingo, M; Peláez, T; Valerio, M | 1 |
| De Lalla, F; Lazzarini, L | 1 |
| Bruss, JB; Edge-Padbury, B; Goldfarb, J; Kaplan, SA; Naberhuis-Stehouwer, S; Saiman, L; Wible, K | 1 |
| Gottlieb, T; Leroi, MJ; Siarakas, S | 1 |
| Alcalá, L; Alonso, R; Bouza, E; Cuevas, O; Peláez, T; Pérez, C | 1 |
2 trial(s) available for oxazolidin-2-one and Diarrhea
| Article | Year |
|---|---|
Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Oxazolidinones; Patient Safety; Recurrence; Vancomycin | 2015 |
Safety and tolerability of linezolid in children.
Topics: Acetamides; Administration, Oral; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cefadroxil; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Diarrhea; Female; Gram-Positive Bacterial Infections; Headache; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Multicenter Studies as Topic; Otitis Media; Oxazolidinones; Pneumonia; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Skin Diseases, Bacterial | 2003 |
8 other study(ies) available for oxazolidin-2-one and Diarrhea
| Article | Year |
|---|---|
Enzyme Inhibitor Antibiotics and Antibiotic-Associated Diarrhea in Critically Ill Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; China; Critical Illness; Diarrhea; Enzyme Inhibitors; Female; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Oxazolidinones; Quinolones; Retrospective Studies | 2018 |
Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Oxazolidinones; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2019 |
Cadazolid, a novel antibiotic with potent activity against Clostridium difficile: safety, tolerability and pharmacokinetics in healthy subjects following single and multiple oral doses.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Blood Chemical Analysis; Clostridioides difficile; Diarrhea; Feces; Healthy Volunteers; Humans; Male; Middle Aged; Oxazolidinones; Placebos; Urine | 2014 |
Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in Mice.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Clostridioides difficile; Colony Count, Microbial; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Intestines; Metronidazole; Mice; Microbial Sensitivity Tests; Oxazolidinones; Streptococcal Infections; Treatment Outcome; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2016 |
Potential protective role of linezolid against Clostridium difficile infection.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Cross Infection; Diarrhea; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Ventilator-Associated; Retrospective Studies; Spain; Treatment Outcome | 2012 |
Failure of intravenous linezolid to treat Clostridium difficile associated diarrhea.
Topics: Acetamides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Linezolid; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Risk Assessment | 2003 |
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fluoroquinolones; Fusidic Acid; Gatifloxacin; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Quinolines; Sensitivity and Specificity; Vancomycin | 2002 |
In vitro activity of linezolid against Clostridium difficile.
Topics: Acetamides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin Resistance | 2002 |